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In November 2010 a new announcement appeared on the website of Integrative Cancer Therapies. The journal is launching an online-only supplement to the paper version that our individual and some institutional subscribers now receive. In this online-only division, we have announced that we will be publishing most letters to the editors, commentaries, case reports, papers with in vitro data only without in vivo data, and other miscellaneous types of submissions. When we have completed paper publication of the already accepted in vitro papers, the paper journal will include human studies, reviews that emphasize human studies, educational articles such as our occasional Integrative Tumor Boards, in vivo and selected in vitro papers that are of special interest, such as ones connected to clinical studies that will also appear in the journal, or those that describe particularly innovative data on, for instance, impacts of herbal medicines on anticancer mechanisms. The onlineonly articles will appear in the Table of Contents of the issue to which they are assigned, which will be as early as possible after acceptance to the journal. A digital object identifier (DOI) and other information needed to access the articles will also be listed. All articles, including those in the print edition, will continue to be posted as "Online First" as soon as possible prior to publication, and will be accessible to paid subscribers through this channel, as well as being available to nonsubscribers for purchase.
The first article in the current issue is by Anthony Hackney at the University of North Carolina at Chapel Hill and colleagues. Exercise prescriptions for cancer patients are getting ever more research attention. One question in this area is whether exercise advice should be altered for patients who have recently completed conventional cancer treatment. Hackeny and colleagues studied exercising post-treatment breast cancer patients, and examined blood lactate and glucose responses, as well as metabolisms of fats and carbohydrates during exercise. They find some significant differences in these areas, which raise interesting questions about whether the differences are results of treatment or are other aspects of cancer as a disease.
Tine and Miha Kovačič of the Center for Education, Work and Care in Slovenia have contributed a randomized study on the use of a yoga program for relaxation following breast cancer surgery. This intervention resulted in a significant reduction in distress, and appears to be a clinically feasible intervention in the situation of Slovenia.
Karen Mustian and colleagues at the University of Rochester are publishing a pilot randomized trial of polarity therapy, a type of energy therapy, and its impact on cancerrelated fatigue. Fatigue is widespread among cancer patients, and is especially notable among breast cancer patients receiving radiation therapy. Non-pharmacological interventions such as polarity therapy may be helpful, and a very welcome intervention for such patients, if further research bears out the potential that this study notes. An interesting feature of this study is the use of a modified massage protocol as a time and attention control. It is important that efficacy studies in the physical and mindbody therapies include credible control groups, and this study suggests that the modified massage protocol could be such an intervention.
The question of how cancer patients employ complementary and alternative (CAM) therapies has been explored very extensively in the United States. However, the U.S. findings are not necessarily relevant to the use of CAM therapies elsewhere in the world. A study of use of CAM therapies by pediatric cancer patients in Lebanon appears in this issue, based on work by Farah Naja and colleagues at the University of Beirut. One of the interesting features that this study notes is use of black cumin, or Nigella sativa, as well as the use of bone ash, by these patients. Nigella sativa is receiving some attention by cancer researchers, and ICT will be publishing a paper on this herb later in 2011. Bone ash is much less studied, and is emblematic of the issues faced in countries where the evidence base on properties of some alternative therapies is still very narrow.
David Hydock and colleagues at the University of Northern Colorado explored the use of exercise training as a possible cardioprotective method during doxorubicin administration in a study using male rats. Doxorubicin is notorious for causing severe cardiac damage during cancer chemotherapy, and a number of supplemental and therapeutic means have been investigated to forestall this characteristic pattern of cardiotoxicity. Exercise training prior to doxorubicin administration in this study resulted in less heart muscle damage in the study animals. An investigation of the molecular effects of the exercise is a very useful component of this study, which will help to elucidate the mechanisms of exercise protection, hopefully leading eventually to therapeutic methods.
While most studies of effects of traditional herbal medicines employ single herbs so that the individual effects of such herbs can be elucidated, the most typical way that herbs have been used in many medical systems is in combination formulas. Tian-Xian Liquid, used in Hong Kong for cancer therapy, is a combination of 10 medicinal herbs including ginseng, cordyceps, ganoderma, scutellaria and other familiar anticancer herbs. A study by Tzi Bun Ng and colleagues in Hong Kong explores the effects of this remedy both in vitro and in vivo, with special attention to antimetastatic, antiproliferative and drug-resistance reversal activities. We feel that studies of combination herbal formulas are of particular interest and relevance in evaluating the true effects of traditional therapeutic systems, and are pleased to be able to publish this contribution.
Curcumin is certainly turning out to be one of the most versatile compounds that is currently of interest in integrative oncology, and in this issue it displays another talent. Chuansuan Xu and colleagues in Chongqing and Hong Kong have explored its use as a sonosensitizer. We have recently published a few other articles on the topic of sonodynamic therapy, an experimental therapy in development that is analogous to the well-established photodynamic therapy. Sensitizers that render cancer cells especially sensitive to effects of ultrasound or light are critical elements in these therapies. This laboratory study demonstrates that curcumin can increase cell kill and apoptosis in nasopharyngeal cancer cells that are exposed to ultrasound, paving the way for further investigation towards a new therapy for this type of cancer, which is of substantial importance in China.
Pradeep Goyal and colleagues at the University of Rajasthan studied the effect of Panax ginseng on mice receiving radiation. Using herbal medicines as potential protective agents during conventional therapy is one of the areas that ICT articles have frequently addressed, and it is certainly an area that deserves attention. This study investigated the effects of ginseng on decreases in erythrocytes and other peripheral blood variables impacted by radiation, in addition to antioxidative effects. While there is always a concern for the possibility of tumor protection in the eventual clinical setting, basic research on radioprotection increases our range of therapies that might turn out to both retard side effects and permit full efficacy of radiotherapy.
Hsiang-Fu Kung of the Chinese University of Hong Kong, along with colleagues, investigated the use of the Chinese herb Ligustrum lucidum in improving chemosensitivity of colon cancer cells to doxorubicin. This herb has a long history of use in Chinese medicine. This study elucidates its activity in promoting the apoptotic sensitivity of cancer cells treated with doxorubicin. Explorations of its effect on T-box genes and p-53 genes are of particular interest in this study.
The actions of individual phytochemicals in herb species are also one of the interesting facets of integrative oncology, since it is only through the actions of phytochemicals that herbs will affect the cells and tissues. Atractylodes macrocephala is one of the widely used Chinese herbs in cancer therapy, and there has been prior investigation of active phytochemicals in this species. Zhi-Ling Yu of Hong Kong Baptist University and colleagues investigate a series of 8 compounds isolated from this species, all of which inhibit growth of melanoma cells. Research on the effects of these compounds on ERK and AKT signaling pathways shows that one of the mechanisms of these phytochemicals could be in this area.
Many integrative studies have been aimed at the solid tumors, such as studies of diet and exercise in breast or prostate cancer, but we should not forget that the hematological cancers have long been one of the preoccupations of natural product drug discovery studies, starting with the development of vincristine and vincaleukoblastine. These drugs were first developed from the Madagascar periwinkle based on their effect on bone marrow. Thus, it is of interest to see a study on antileukemic effects of a Chinese herb, Gynostemma pentaphyllum, from Jing-Gun Chung and colleagues in Taiwan. These authors note that G. pentaphyllum has been used traditionally in cancer treatment -but it also has recently been tested in a randomized trial in patients with type 2 diabetes in which it promptly improved glycemia and insulin sensitivity. In the present study, these authors examined effects of G. pentaphyllum on apoptosis in leukemia cells, through mitochondria-dependent pathways. They also observed an improvement in survival rate of mice bearing leukemic cells. Given that chronic lymphocytic leukemia is in many ways a disorder of apoptosis, findings of this type are of great interest.
Finally, we would like to thank the many reviewers who worked with us during the year 2010 in handling the increased volume of submissions we received. Over the last two years, the journal has experienced a major increase in volume of submissions, entailing more reliance than ever on our reviewers. These reviewers are a critical resource in helping us keep the quality of the journal high, and deserve our highest gratitude. The 2010 reviewers are the following: Premila Abraham, Donald Abrams, Michiyo Ando, Manu Aryan, Carlos Austerlitz, Jan Baak, Suresh Babu, Lynda Balneaves, Claudio Battaglini, Robin Bell, Tony Bifero, P. Bischoff, Felicity Bishop, Thomas Blank, Penny Block, Heather Boon, Terence Bugno, Godfrey Chi-Fung Chan, Yuan-Shiun Chang, Kevin Chen, Chin-Wen Chi, B.-L. Chiang, Lew-Ting Chin-Yin, Jen-Hwey Chiu, Gerald Chodak, S.P. Choo, Jing-Gung Chung, Jiunn-Jye Chuu, D.J. Conklin, Corinne Crammer, J.N. Crane, Malgorzata Czyz, Shao Chun Dai,
